Sign in
ZLDPF Stock Price, Chart, Stats & News
Zealand Pharma A/S
Save
Zealand Pharma A/S (ZLDPF) does not currently pay a dividend.
3.73B
Market cap
8.74x
Current P/E
–
Forward P/E
ZLDPF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Based in Copenhagen, Denmark, Zealand Pharma A/S operates as a biotechnology company dedicated to the entire lifecycle of peptide-based medicines – from their initial discovery and development through to their ultimate commercialization. Its therapeutic portfolio primarily targets gastrointestinal and metabolic disorders, alongside other specialized conditions where existing treatments are insufficient. Currently, Zealand Pharma offers lixisenatide, marketed as Adlyxin and Lyxumia.
Similar securities
Based on sector and market capitalization
Report issue